📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. (2016)

First Author: Zheng F

Attributed to: Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/ncomms10180

PubMed Identifier: 26782714

Publication URI: http://europepmc.org/abstract/MED/26782714

Type: Journal Article/Review

Volume: 7

Parent Publication: Nature communications

ISSN: 2041-1723